HAVCR1 and Balkan nephropathy: Treatment with fms-I over days 14 to 28 halted the progression of established AAN as shown by preventing a further loss of renal function, preventing the development of proteinuria and less severe tubular damage based on PAS staining and KIM-1 expression (Figures 5A-5C and 6A-6C).